相关实验视频

Updated: Dec 9, 2025

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Published on: July 25, 2020

在17q23放大乳腺癌中准TRIM37驱动的中心细胞功能障碍

Zhong Y Yeow^1,2, Bramwell G Lambrus³, Rebecca Marlow^4,5

¹Medical Research Council (MRC) Molecular Haematology Unit, Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, UK.

|September 10, 2020

概括

向波罗类激酶4 (PLK4) 导致17q23安普利康的合成致死性. 这发生在TRIM37过度表达破坏细胞分裂时,突出显示了基因组不稳定的新治疗策略.

科学领域:

癌症学
遗传学
细胞生物学

背景情况:

基因组不稳定是乳腺癌发病和进展的关键因素.
聚ADP核糖聚合酶抑制剂在治疗同源复合缺陷乳腺癌方面表现出成功,证明了合成致死性的潜力.
导致乳腺癌基因组不稳定的其他机制需要确定新的治疗策略.

研究的目的:

通过17q23安普利康来研究心体枯竭作为乳腺癌的合成致死方法.
确定TRIM37作为一个关键的调节器,并探索其在基因组不稳定中的作用.

主要方法:

使用小分子抑制波罗样酶4 (PLK4) 来诱导中心体枯竭.
分析TRIM37作为中心体周中心物质调节者的作用.
评估因中心体枯竭和TRIM37水平而导致的线粒错误和基因组不稳定性.

主要成果:

通过PLK4抑制的中枢细胞枯竭会触发17q23安普利康在癌细胞中的合成致死性.
作为细胞分裂的关键,TRIM37 作为细胞中心周围物质的负调节剂.
在中枢细胞枯竭的细胞中,TRIM37的过度表达会导致线粒体灾难和基因组不稳定.

结论:

在17q23放大乳腺癌中,TRIM37依赖的基因组不稳定是驱动事件.
过度表达TRIM37通过损害中心体成熟和分离而加剧基因组不稳定性.
中心细胞向药物代表了这种乳腺癌亚组的潜在治疗策略.

更多相关视频

Identifying the Effects of BRCA1 Mutations on Homologous Recombination using Cells that Express Endogenous Wild-type BRCA1

Identifying the Effects of BRCA1 Mutations on Homologous Recombination using Cells that Express Endogenous Wild-type BRCA1

Published on: February 17, 2011

Cell Death Associated with Abnormal Mitosis Observed by Confocal Imaging in Live Cancer Cells

Cell Death Associated with Abnormal Mitosis Observed by Confocal Imaging in Live Cancer Cells

Published on: August 21, 2013

相关概念视频

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

Centrosome Duplication

Centrosome Duplication

The primary microtubule organizing center (MTOC) in animal cells is the centrosome. A centrosome has two cylindrical centrioles at its core. Each centriole consists of nine sets of three microtubules held together by proteins. The centrioles are positioned at right angles to each other and surrounded by a shapeless protein cloud called the pericentriolar matrix, or pericentriolar material (PCM).
To ensure that each daughter cell receives a centrosome after cell division, centrosome duplication...